Filter
7019
Filtered Results: 7019
Text search:
access
medicines
Featured
Recommendations
608
New Publications
1769
Language
Document type
No document type
3806
Studies & Reports
1379
Guidelines
857
Manuals
368
Strategic & Response Plan
264
Fact sheets
122
Training Material
103
Situation Updates
69
Resource Platforms
22
Infographics
12
Brochures
9
Online Courses
6
App
1
Videos
1
Countries / Regions
India
289
Global
265
Kenya
209
South Africa
173
Ethiopia
150
Uganda
139
Nepal
129
Nigeria
126
Sierra Leone
124
Western and Central Europe
124
Latin America and the Carribbean
116
Liberia
113
Tanzania
110
Africa
107
Malawi
103
Bangladesh
97
Zambia
92
Ukraine
91
Myanmar / Burma
89
Syria
84
Rwanda
81
Ghana
80
Venezuela
60
Congo, Democratic Republic of
59
Philippines
54
Zimbabwe
53
Eastern Europe
50
Namibia
48
South–East Asia Region
47
Mozambique
45
Asia
41
Lesotho
37
West and Central Africa
36
East and Southern Africa
36
Brazil
36
Colombia
35
Senegal
34
Cambodia
34
Haiti
33
Yemen
33
Guinea
32
South Sudan
32
Russia
30
Indonesia
27
Cameroon
26
Germany
26
Middle East and North Africa
26
Burkina Faso
24
Botswana
24
Benin
20
Paraguay
20
Eswatini/ Swaziland
19
Afghanistan
18
Peru
18
Eastern Europe and Central Asia
18
Pakistan
18
Thailand
16
Sudan
16
Bolivia
15
Vietnam
15
USA
14
Lebanon
14
Moldova
13
Somalia
13
Tajikistan
12
Jordan
12
Western Pacific Region
11
Sri Lanka
11
Mali
11
China
10
Chile
10
Argentina
10
Georgia
10
Central African Republic
10
Ecuador
10
Albania
9
North Macedonia
8
Mexico
8
El Salvador
8
Laos
8
North America
8
Iraq
8
Madagascar
8
Turkey
7
Southern Africa
7
Palestine
7
Spain
6
Poland
6
Kazakhstan
5
Iran
5
Kyrgyzstan
5
Jamaica
5
United Kingdom
5
Côte d’Ivoire / Ivory Coast
5
Egypt
5
Guatemala
5
Canada
4
Burundi
4
Hungary
4
Saudi Arabia
4
Turkmenistan
4
Papua New Guinea
4
Romania
4
Libya
4
Timor Leste/ East Timor
3
Serbia
3
Gambia
3
Togo
3
Niger
3
Uzbekistan
3
Armenia
3
Portugal
3
Belarus
3
Greece
3
Angola
3
Chad
3
Switzerland
2
Estonia
2
Malaysia
2
Morocco
2
Qatar
2
Bulgaria
2
Italy
2
Guinea-Bissau
2
Lithuania
2
Japan
2
France
2
Mauritius
2
Bosnia and Herzegovina
2
Nicaragua
2
Bhutan
2
Australia
1
Fiji
1
Singapore
1
Congo-Brazzaville
1
Austria
1
Mongolia
1
Mauritania
1
Dominican Republic
1
Gabon
1
Uruguay
1
Denmark
1
Maldives
1
Tunisia
1
Norway
1
South Korea
1
French Guyana
1
Israel
1
Djibouti
1
Slovakia
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
2633
Clinical Guidelines
549
Public Health
408
Women & Child Health
316
Key Resources
304
Capacity Building
119
Pharmacy & Technologies
76
Annual Report MEDBOX
3
Toolboxes
HIV
613
COVID-19
578
Mental Health
565
TB
415
AMR
280
NTDs
224
Disability
223
Caregiver
211
Planetary Health
206
Conflict
186
Pharmacy
179
Ebola & Marburg
173
NCDs
171
Rapid Response
148
Global Health Education
118
Refugee
114
Natural Hazards
68
Health Financing Toolbox
60
Zika
37
Social Ethics
29
Specific Hazards
26
Cholera
26
Polio
17
Malaria
1
Typhoon
1
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 20...
Millions of people today cannot access medicine when they need to. This can be due to price, empty pharmacy shelves or other factors. Find out more about the situation and how the Index stimulates pharmaceutical companies to help turn it around.
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan...
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
Complete version of MDS-3 publication - Managing Drug Supply (MDS) is the leading reference on how to manage essential medicines in developing countries. MDS was originally published in 1982. It was revised in 1997 with over 10,000 copies distributed in over 60 countries worldwide. The third edition...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
Background
Access to medicines is important for long‐term care of cardiovascular diseases and hypertension. This study provides a cross‐country assessment of availability, prices, and affordability of cardiovascular disease and hypertension medicines to identify areas for improvement in access ...
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in the hospital and secondly, a call for an action to be taken in improving hospital pharmacies developm...
Heart failure (HF) is a leading global public health problem with >64 million prevalent cases globally. Patients with HF with reduced ejection fraction (HFrEF) from low- and middle-income countries experience a 22% to 58% higher 1-year mortality rate than those in high-income countries.1 Guideline-d...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
The Ukrainian refugee crisis has received prompt attention not only from concerned citizens outside Ukraine and the United Nations agencies but also from the European Commission (EC). For the first time, the Temporary Protection Directive 2001/55/EC was activated, enabling immediate access to health...
Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched. In the past few decades, deaths from NCDs in LMICs have spiked, whereas numbers in high-income countries have stabilis...
Chapter 16: Managing medicine selection - Key topics: the concept of essential medicines; selection of essential medicines and development of essential medicines lists, formularies, and treatment guidelines. - The rationale for selecting a limited number of essential medicines is that it may lead ...
Pharmaceutical system assessments are useful to diagnose problems, plan major projects and interventions, monitor progress, and compare the performance of one system with that of another. Recent years have seen a growth in demand for such assessments because of the global Fund to Fight AIDS, Tubercu...
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac...
